CLASS II ONGOING Device recall · Reported 8 Mar 2023 · FDA Enforcement Report

Biofinity XR Toric Single Diagnostic lens- Soft recalled by CooperVision

CooperVision is recalling Biofinity XR Toric Single Diagnostic lens- Soft (hydrophilic) Contact Lens (extended wear), distributed nationwide in the US. The recall was initiated on 26 Jan 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: N/A Lot Numbers: R24395839, R24406094, R24409954
Quantity recalled4 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1198-2023
FDA event ID
91607
Recalling firm
CooperVision, West Henrietta, NY
Classification
Class II
Status
Ongoing
Recall initiated
26 Jan 2023
FDA classified
1 Mar 2023
Reported
8 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

26 Jan 2023Recall initiated by company
1 Mar 2023Classified by FDA+34 days
8 Mar 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Manufactured with misaligned axis resulting in lenses with the incorrect power, users may experience poor visual acuity

Product as listed by the FDA

Biofinity XR Toric Single Diagnostic lens- Soft (hydrophilic) Contact Lens (extended wear)

Where it was distributed

US Nationwide distribution in the states of CA, OH, NC, PA.

Nationwide CaliforniaNorth CarolinaOhioPennsylvania

Questions about this recall

Is Biofinity XR Toric Single Diagnostic lens- Soft (hydrophilic) Contact Lens (extended wear) recalled?

Yes. CooperVision recalled Biofinity XR Toric Single Diagnostic lens- Soft (hydrophilic) Contact Lens (extended wear) on 26 Jan 2023. The recall is Class II and its status is Ongoing. Recall number Z-1198-2023.

Why was it recalled?

Manufactured with misaligned axis resulting in lenses with the incorrect power, users may experience poor visual acuity

Which lots are affected?

UDI: N/A Lot Numbers: R24395839, R24406094, R24409954

Where was it sold?

US Nationwide distribution in the states of CA, OH, NC, PA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from CooperVision

All 33

Other Test Kits & Diagnostics recalls

All 2,656